They would likely have a risk rating associated with things that...

They would likely have a risk rating associated with things that could potentially block or delay the project and add incremental milestones that would be catalysts for increases post the $1 value. $3bill+ is a lofty market cap for a non-producer IMO (not that I'm complaining, it's been a long hard run to here). I believe there is a huge amount of upside from here to come, but realistically the majority of gains from here I'm expecting after we prove we can start producing outside of the lab